2012 Lung Cancer Research Foundation Annual Grant Program
Donald Kufe, MD
Dana-Farber Cancer Institute
Research Project:
Targeting the MUC1-C Oncoprotein with Novel Agents for the Treatment of Drug-Resistant NSCLC
Summary:
Study to investigate the mechanism of resistance occurring in some patients with lung cancer after conventional treatment related to a specific gene mutation. This understanding could lead to more effective use of existing drugs as well as development of new agents.